UBS Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
UBS Group's ZBH Position: Q3 2026 in Review
UBS Group reduced its Zimmer Biomet (ZBH) stake by 59% in Q3 2026, selling an estimated $155M and leaving 1,127,503 shares worth $100M. The position accounts for 0.01% of the portfolio, ranked #1091.
UBS Group first reported a position in ZBH in Q4 2014 and has held it in 48 quarters since. The position peaked at $237M in Q2 2026. 931 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.
- UBS Group held 1,127,503 shares of Zimmer Biomet worth $100M as of Q3 2026.
- UBS Group sold 1,631,112 Zimmer Biomet shares in Q3 2026, an estimated $155M.
- Zimmer Biomet made up 0.01% of UBS Group's portfolio in Q3 2026, its #1091 holding.
- UBS Group first reported a position in Zimmer Biomet in Q4 2014 and has held it in 48 quarters since.
- UBS Group's Zimmer Biomet position peaked at $237M in Q2 2026.
- 931 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.